Buprenorphine, rather than a full agonist opioid, should be used for patients taking daily opioids for chronic pain, given its lower risk for overdose or misuse, new guidelines from the Department of ...

Please provide your email address to receive an email when new articles are posted on . The state of pain management in rheumatology has always been in flux. However, after the explosion of the opioid ...

How does your doctor actually prescribe opioid medication? Why is it hard to get a refill? What are the best solutions to help patients with pain?

"The effects of a provincial opioid prescribing standard on opioid prescribing for pain in adults: an interrupted time-series analysis" and "Integrating chronic pain management into care for patients ...

Please provide your email address to receive an email when new articles are posted on . To some extent, 58% of respondents felt comfortable prescribing long-term opioids. However, 81% had concern ...

To evaluate the long-term efficacy and tolerability of a representative extended-release (ER)/long-acting (LA) opioid in a 12-month placebo-controlled trial, FDA staff are considering an enriched ...

Rutgers has granted Tonix Pharmaceutical exclusive worldwide rights to develop and commercialize a novel class of compounds ...

A breakthrough study suggests that cannabis-derived compounds, known as terpenes, may provide a new solution for chronic pain relief, potentially reducing reliance on opioids. Conducted by researchers ...

Forbes contributors publish independent expert analyses and insights. Dario Sabaghi covers the cannabis industry with a focus on Europe. More Americans use cannabis to treat chronic pain as an ...

During the opioid crisis in the United States, acute pain management has remained a persistent challenge for both patients ...

At least 1 in 5 Americans suffers from chronic pain and nearly 1 in 10 are disabled by it. Medications are either not enough, cause dangerous side effects or even making the pain worse. To better ...